32 projects completed under PLI Scheme for promotion of domestic manufacturing of Critical KSMs/DIs and APIs
Policy

32 projects completed under PLI Scheme for promotion of domestic manufacturing of Critical KSMs/DIs and APIs

Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme

  • By IPP Bureau | August 10, 2024

32 projects with cumulative installed capacity of 56,679 MT per annum have been completed under PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in the country says Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Lok Sabha in reply to a question. 

Against targeted investment of Rs. 3,938 crores, investments worth Rs. 4,024 crore have been made under the scheme. 

The Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)and Active Pharmaceutical Ingredients (APIs) in the country with a financial outlay of Rs. 6,940 crore was approved by the Cabinet to boost domestic manufacturing of bulk drugs in the country, reduce import dependence and improve our supply chain resilience. The production period under the scheme is from FY 2022-23 to FY 2028-29. 

Under the scheme, 249 applications were received, of which 48 projects have been selected for manufacturing of identified bulk drugs. 13 of these projects are implemented by 10 Micro, Small and Medium Enterprises (MSMEs).  

Under the scheme, 32 projects have been completed with cumulative installed capacity of 56,679 MT per annum. 16 projects are under development and have been supported for facilitating regulatory approvals such as environmental clearance and drug manufacturing licenses with the help of state governments. Against the targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crore have been made under the scheme. 

PLI scheme for Promotion of Domestic Manufacturing of Critical KSMs/DIs and APIs

Andhra Pradesh

1. Lyfius Pharma Pvt. Limited - Penicillin G

2. Granules India Limited - Dicyandiamide (DCDA)

3. Andhra Organics Limited - Olmesartan

4. Andhra Organics Limited - Sulfadiazine

5. Andhra Organics Limited - Telmisartan

6. Hetero Drugs Limited - Carbidopa

7. Hetero Drugs Limited - Levodopa

8. Honour Lab Limited - Lopinavir

9. Honour Lab Limited - Vitamin B6

10. Kreative Actives Private Limited (MSME) - Diclofenac Sodium 

Gujarat

1. Macleods Pharmaceutical Limited - Rifampicin

2. Meghmani LLP - Para Amino Phenol

3. Amoli Organics Private Limited - Diclofenac Sodium

4. Aviran Pharmachem Private Limited (MSME) - Artesunate

5. Globela Industries Private Limited (MSME) - Norfloxacin

6. Globela Industries Private Limited (MSME) - Ofloxacin

7. Vital Laboratories Private Limited (MSME) - Levofloxacin

8. Vital Laboratories Private Limited (MSME) - Ofloxacin 

Himachal Pradesh

1. Kinvan Private Limited - Clavulanic Acid 

Jammu & Kashmir

1. Orchid Bio-Pharma Limited - 7 ACA 

Karnataka

1. Natural Biogenex Private Limited - Betamethasone

2. Natural Biogenex Private Limited - Dexamethasone

3. Natural Biogenex Private Limited - Prednisolone 

Madhya Pradesh

1. Karnataka Antibiotics and Pharmaceuticals Limited - 7 ACA

2. Symbiotec Pharmalab Private Limited - Prednisolone 

Maharashtra

1. Sadhana Nitro Chem Limited (MSME) - Para Amino Phenol

2. Alta Laboratories Limited - Aspirin

3. Lifetech Sciences (MSME) - Ritonavir

4. RMC Performance Chemicals Private Limited (MSME) - Aspirin

5. Sudarshan Pharma Industries Limited (MSME) - Vitamin B1 

6. Sudarshan Pharma Industries Limited (MSME) - Vitamin B6 

Punjab

1. Centrient Pharmaceuticals India Private Limited - Atorvastatin 

Rajasthan

1. Rajasthan Antibiotics Limited - Meropenem 

Tamil Nadu

1. Global Pharma Healthcare Private Limited (MSME) - Ofloxacin

2. K P Manish Global Ingredients Private Limited - Artesunate 

Telangana

1. Emmennar Pharma Private Limited (MSME) - 1,1 Cyclohexane Diacetic Acid (CDA)

2. Hindys Lab Private Limited - 1,1 Cyclohexane Diacetic Acid (CDA)

3. Anasia Lab Private Limited - Losartan

4. Anasia Lab Private Limited - Olmesartan

5. Dasami Lab Private Limited - Oxcarbazepine

6. Dasami Lab Private Limited - Oxcarbazepine

7. Hazelo Lab Private Limited - Vitamin B6

8. Hetero Drugs Limited - Levofloxacin

9. Hetero Drugs Limited - Oxcarbazepine

10. Hindys Lab Private Limited - Acyclovir

11. Honour Lab Limited - Levetiracetam

12. Honour Lab Limited - Valsartan

13. MSN Life Sciences Private Limited - Levofloxacin

Upcoming E-conference

Other Related stories

Startup

Digitization